Funds holding XTL BIOPHARMACEUTICALS LTD
ISIN US98386D3070 · Israel · LEI 529900NDDXEAPTUTXP41
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 6.8K $
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 8,903 | 6.8K $ | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 8,903 | 0.0 % |
| 2026Q1 | 1 | 0 | 8,903 | 0.0 % |
| 2025Q4 | 1 | 0 | 8,903 | 0.0 % |
| 2025Q3 | 1 | 0 | 8,903 | 0.0 % |
| 2025Q2 | 1 | 0 | 8,903 | 0.0 % |
| 2025Q1 | 1 | 0 | 8,903 | 0.0 % |
| 2024Q4 | 1 | 0 | 8,903 | 0.0 % |
| 2024Q3 | 1 | 0 | 8,903 | 0.0 % |
| 2024Q2 | 1 | 0 | 8,903 | 0.0 % |
| 2024Q1 | 1 | 0 | 8,903 | 0.0 % |
| 2023Q4 | 1 | 8,903 |
Cite this page
Titelia. "Funds holding XTL BIOPHARMACEUTICALS LTD". https://titelia.com/en/stocks/xtl-biopharmaceuticals-ltd-US98386D3070